GREEN after Consultant/Specialist initiation. (Decision date - August 2020).
To be used for licensed indications only.
Patients with metastatic prostate cancer will be seen in clinic and will be initiated on bicalutamide. A 3monthly LHRH injection will be issued to the patient to take to the GP for administration between 7-14 days after initiation of bicalutamide.
DNP as per The Medicines Emergency Prohibition Order 2024 for new patients under 18 years of age for the purposes of puberty suppression in those experiencing gender dysphoria or incongruence. (Decision date - June 2024)